Brian V. Broberg
About
Brian V. Broberg is a scholar working on Cellular and Molecular Neuroscience, Psychiatry and Mental health and Biological Psychiatry.
According to data from OpenAlex, Brian V. Broberg has authored 36 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cellular and Molecular Neuroscience, 15 papers in Psychiatry and Mental health and 10 papers in Biological Psychiatry. Recurrent topics in Brian V. Broberg's work include Neuroscience and Neuropharmacology Research (17 papers), Schizophrenia research and treatment (13 papers) and Tryptophan and brain disorders (10 papers). Brian V. Broberg is often cited by papers focused on Neuroscience and Neuropharmacology Research (17 papers), Schizophrenia research and treatment (13 papers) and Tryptophan and brain disorders (10 papers). Brian V. Broberg collaborates with scholars based in Denmark, United States and Netherlands. Brian V. Broberg's co-authors include Birte Glenthøj, Egill Rostrup, Nikolaj Bak, Bjørn H. Ebdrup, Mette Ødegaard Nielsen, Christina Kurre Olsen, Filip K. Knop, Rebecca Dias, Pelle L. Ishøy and Sanne Wulff and has published in prestigious journals such as Biological Psychiatry, Journal of Neurochemistry and Cerebral Cortex.
In The Last Decade
Brian V. Broberg
35 papers receiving 994 citations
Peers
Brian V. Broberg
Dachun Chen China
Frederic Sampedro Spain
Colleen Dockery Czechia
Erkki Tupala Finland
Markus Sack Germany
Antony J. Harding Australia
J. H. Morrison United States
Renate Stauch Germany
Bernadett Tuka Hungary
Ari Illi Finland
Citations per year, relative to Brian V. Broberg Brian V. Broberg (= 1×)
peers
Dachun Chen
Countries citing papers authored by Brian V. Broberg
Since
Specialization
Citations
This map shows the geographic impact of Brian V. Broberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian V. Broberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian V. Broberg more than expected).
Fields of papers citing papers by Brian V. Broberg
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Brian V. Broberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian V. Broberg. The network helps show where Brian V. Broberg may publish in the future.
Co-authorship network of co-authors of Brian V. Broberg
This figure shows the co-authorship network connecting the top 25 collaborators of Brian V. Broberg. A scholar is included among the top collaborators of Brian V. Broberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian V. Broberg. Brian V. Broberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Ebdrup, Bjørn H., Mikkel Sørensen, Brian V. Broberg, et al.. (2022). Lower Vitamin C Levels Are Associated With Less Improvement in Negative Symptoms in Initially Antipsychotic-Naïve Patients With First-Episode Psychosis. The International Journal of Neuropsychopharmacology. 25(8). 613–618.
2.
Wenneberg, Christina, Birte Glenthøj, Louise Birkedal Glenthøj, et al.. (2020). Baseline measures of cerebral glutamate and GABA levels in individuals at ultrahigh risk for psychosis: Implications for clinical outcome after 12 months. European Psychiatry. 63(1). e83–e83.
3.
Bojesen, Kirsten Borup, Brian V. Broberg, Birgitte Fagerlund, et al.. (2020). Associations Between Cognitive Function and Levels of Glutamatergic Metabolites and Gamma-Aminobutyric Acid in Antipsychotic-Naïve Patients With Schizophrenia or Psychosis. Biological Psychiatry. 89(3). 278–287.
4.
Wenneberg, Christina, Merete Nordentoft, Egill Rostrup, et al.. (2019). Cerebral Glutamate and Gamma-Aminobutyric Acid Levels in Individuals at Ultra-high Risk for Psychosis and the Association With Clinical Symptoms and Cognition. Biological Psychiatry Cognitive Neuroscience and Neuroimaging. 5(6). 569–579.
5.
Wenneberg, Christina, Birte Glenthøj, Carsten Hjorthøj, et al.. (2019). Supplementary data for a focused review and meta-analysis of 1H-MRS studies on cerebral glutamate and GABA levels in high-risk of psychosis states. Data in Brief. 28. 104920–104920.
6.
Eriksson, Robert, Brian V. Broberg, Pelle L. Ishøy, et al.. (2019). Bone Status in Obese, Non-diabetic, Antipsychotic-Treated Patients, and Effects of the Glucagon-Like Peptide-1 Receptor Agonist Exenatide on Bone Turnover Markers and Bone Mineral Density. Frontiers in Psychiatry. 9. 781–781.
7.
Wenneberg, Christina, Birte Glenthøj, Carsten Hjorthøj, et al.. (2019). Cerebral glutamate and GABA levels in high-risk of psychosis states: A focused review and meta-analysis of 1H-MRS studies. Schizophrenia Research. 215. 38–48.
8.
Egerton, Alice, Brian V. Broberg, Neeltje E.M. van Haren, et al.. (2018). Response to initial antipsychotic treatment in first episode psychosis is related to anterior cingulate glutamate levels: a multicentre 1H-MRS study (OPTiMiSE). Molecular Psychiatry. 23(11). 2145–2155.
9.
Bojesen, Kirsten Borup, et al.. (2018). Glutamate Levels and Resting Cerebral Blood Flow in Anterior Cingulate Cortex Are Associated at Rest and Immediately Following Infusion of S-Ketamine in Healthy Volunteers. Frontiers in Psychiatry. 9. 22–22.
10.
Nordholm, Dorte, Egill Rostrup, Valeria Mondelli, et al.. (2018). Multiple measures of HPA axis function in ultra high risk and first-episode schizophrenia patients. Psychoneuroendocrinology. 92. 72–80.
11.
Broberg, Brian V., Iris E. Sommer, Michael E. Benros, et al.. (2018). Glucocorticoids and the risk of schizophrenia spectrum disorder in childhood and adolescence – A Danish nationwide study. Schizophrenia Research. 199. 116–122.
12.
Broberg, Brian V., Rachel M. Brouwer, Rikke Hilker, et al.. (2018). Heritability of cerebral glutamate levels and their association with schizophrenia spectrum disorders: a 1[H]-spectroscopy twin study. Neuropsychopharmacology. 44(3). 581–589.
13.
Coello, Klara, Brian V. Broberg, Nikolaj Bak, et al.. (2015). Postprandial prolactin suppression appears absent in antipsychotic-treated male patients. Psychoneuroendocrinology. 60. 1–6.
14.
Ishøy, Pelle L., Filip K. Knop, Brian V. Broberg, et al.. (2014). Treatment of antipsychotic-associated obesity with a GLP-1 receptor agonist—protocol for an investigator-initiated prospective, randomised, placebo-controlled, double-blinded intervention study: the TAO study protocol. BMJ Open. 4(1). e004158–e004158.
15.
Ishøy, Pelle L., et al.. (2014). Treatment of antipsychotic-associated obesity with a GLP-1 receptor agonist-protocol for an investigator-initiated prospective, randomised, placebo-controlled, double-blinded intervention study:The TAO study protocol. Research at the University of Copenhagen (University of Copenhagen).
16.
Broberg, Brian V., Kristoffer H. Madsen, Niels Plath, et al.. (2013). A schizophrenia rat model induced by early postnatal phencyclidine treatment and characterized by Magnetic Resonance Imaging. Behavioural Brain Research. 250. 1–8.
17.
Kjærby, Celia, Brian V. Broberg, Uffe Kristiansen, & Nils Ole Dalby. (2013). Impaired GABAergic Inhibition in the Prefrontal Cortex of Early Postnatal Phencyclidine (PCP)-Treated Rats. Cerebral Cortex. 24(9). 2522–2532.
18.
Lau, Colleen L., et al.. (2011). The Rho kinase inhibitor Fasudil up‐regulates astrocytic glutamate transport subsequent to actin remodelling in murine cultured astrocytes. British Journal of Pharmacology. 163(3). 533–545.
19.
Broberg, Brian V., Bob Oranje, Birte Glenthøj, et al.. (2010). Assessment of auditory sensory processing in a neurodevelopmental animal model of schizophrenia—Gating of auditory-evoked potentials and prepulse inhibition. Behavioural Brain Research. 213(2). 142–147.
20.
Broberg, Brian V., et al.. (2009). Reversal of cognitive deficits by an ampakine (CX516) and sertindole in two animal models of schizophrenia—sub-chronic and early postnatal PCP treatment in attentional set-shifting. Psychopharmacology. 206(4). 631–640.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Dachun Chen Breakdown of academic impact, for papers by Frederic Sampedro Breakdown of academic impact, for papers by Colleen Dockery Breakdown of academic impact, for papers by Erkki Tupala Breakdown of academic impact, for papers by Markus Sack Breakdown of academic impact, for papers by Antony J. Harding Breakdown of academic impact, for papers by J. H. Morrison Breakdown of academic impact, for papers by Renate Stauch Breakdown of academic impact, for papers by Bernadett Tuka Breakdown of academic impact, for papers by Ari Illi